Financhill
Sell
26

MNY Quote, Financials, Valuation and Earnings

Last price:
$0.80
Seasonality move :
45.83%
Day range:
$0.73 - $0.81
52-week range:
$0.65 - $2.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.35x
P/B ratio:
0.56x
Volume:
74.7K
Avg. volume:
62.6K
1-year change:
-57.92%
Market cap:
$31.6M
Revenue:
$80.7M
EPS (TTM):
-$3.30
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- $61.9M $68.1M $80.7M
Revenue Growth (YoY) -- -- -- 10.1% 18.4%
 
Cost of Revenues -- -- $29.9M $33.9M $43.9M
Gross Profit -- -- $32M $34.3M $36.7M
Gross Profit Margin -- -- 51.71% 50.27% 45.54%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $53.2M $64.6M $124.9M
Other Inc / (Exp) -- -- -$3.2M -$5M -$56.7M
Operating Expenses -- -- $58.1M $71.2M $134.5M
Operating Income -- -- -$26.1M -$36.9M -$97.7M
 
Net Interest Expenses -- -- $1.7M $7.8M $18.2M
EBT. Incl. Unusual Items -- -- -$31M -$49.7M -$172.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -$38.2K -$251.8K $63K
Net Income to Company -- -- -$31M -$49.7M -$172.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$30.9M -$49.4M -$172.6M
 
Basic EPS (Cont. Ops) -- -- -$0.83 -$1.33 -$17.92
Diluted EPS (Cont. Ops) -- -- -$0.83 -$1.33 -$17.92
Weighted Average Basic Share -- -- $37.2M $37.2M $9.6M
Weighted Average Diluted Share -- -- $37.2M $37.2M $9.6M
 
EBITDA -- -- -$25.4M -$37.1M -$146.3M
EBIT -- -- -$29.3M -$41.9M -$153.5M
 
Revenue (Reported) -- -- $61.9M $68.1M $80.7M
Operating Income (Reported) -- -- -$26.1M -$36.9M -$97.7M
Operating Income (Adjusted) -- -- -$29.3M -$41.9M -$153.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $17.3M $19.7M $20.9M
Revenue Growth (YoY) -- -- -- 13.78% 6.18%
 
Cost of Revenues -- -- $9M $10.7M $12.2M
Gross Profit -- -- $8.4M $9M $8.7M
Gross Profit Margin -- -- 48.26% 45.87% 41.52%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $18.7M $11.2M $13.2M
Other Inc / (Exp) -- -- -$3.8M -$1.4M $12.2M
Operating Expenses -- -- $20.3M $13M $15.1M
Operating Income -- -- -$12M -$4M -$6.4M
 
Net Interest Expenses -- -- $1.3M $1.8M $4K
EBT. Incl. Unusual Items -- -- -$17.1M -$7.2M $5.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -$262K $25K $33K
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$16.8M -$7.2M $5.7M
 
Basic EPS (Cont. Ops) -- -- -$0.45 -$0.19 $0.10
Diluted EPS (Cont. Ops) -- -- -$0.45 -$0.19 $0.10
Weighted Average Basic Share -- -- $37.2M $37.2M $41M
Weighted Average Diluted Share -- -- $37.2M $37.2M $41M
 
EBITDA -- -- -$15.7M -$5.4M $5.8M
EBIT -- -- -$15.7M -$5.4M $5.8M
 
Revenue (Reported) -- -- $17.3M $19.7M $20.9M
Operating Income (Reported) -- -- -$12M -$4M -$6.4M
Operating Income (Adjusted) -- -- -$15.7M -$5.4M $5.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $71.5M $90.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $34.4M $57.7M
Gross Profit -- -- -- $37.1M $32.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $50.1M $134.7M
Other Inc / (Exp) -- -- -$3.8M -$54.8M $11.7M
Operating Expenses -- -- -- $57.1M $145.1M
Operating Income -- -- -- -$20M -$112.7M
 
Net Interest Expenses -- -- $1.3M $6.3M $12.8M
EBT. Incl. Unusual Items -- -- -- -$81.1M -$113.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $66.2K $93K
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$81.2M -$113.9M
 
Basic EPS (Cont. Ops) -- -- -- -$2.18 -$3.30
Diluted EPS (Cont. Ops) -- -- -- -$2.18 -$3.30
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -$74.7M -$100.1M
EBIT -- -- -- -$74.7M -$100.1M
 
Revenue (Reported) -- -- -- $71.5M $90.2M
Operating Income (Reported) -- -- -- -$20M -$112.7M
Operating Income (Adjusted) -- -- -- -$74.7M -$100.1M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue -- $17.3M $54.3M $63.8M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $9M $26.3M $40.1M --
Gross Profit -- $8.4M $27.9M $23.6M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $18.7M $34.3M $44.1M --
Other Inc / (Exp) -- -$3.8M -$61.4M $7M --
Operating Expenses -- $20.3M $39.4M $50.1M --
Operating Income -- -$12M -$11.5M -$26.5M --
 
Net Interest Expenses -- $1.3M $5.4M $17K --
EBT. Incl. Unusual Items -- -$17.1M -$78.2M -$19.5M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -$262K $60K $90K --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$16.8M -$78.3M -$19.6M --
 
Basic EPS (Cont. Ops) -- -$0.45 -$2.10 -$0.50 --
Diluted EPS (Cont. Ops) -- -$0.45 -$2.10 -$0.50 --
Weighted Average Basic Share -- $37.2M $111.7M $125.4M --
Weighted Average Diluted Share -- $37.2M $111.7M $125.4M --
 
EBITDA -- -$15.7M -$72.9M -$19.5M --
EBIT -- -$15.7M -$72.9M -$19.5M --
 
Revenue (Reported) -- $17.3M $54.3M $63.8M --
Operating Income (Reported) -- -$12M -$11.5M -$26.5M --
Operating Income (Adjusted) -- -$15.7M -$72.9M -$19.5M --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- -- $24.1M $68.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $9.7M $17.2M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $48.6M $106.9M
 
Property Plant And Equipment -- -- -- $1.1M $780.2K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- $14.4M $7.3M
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $64.3M $115M
 
Accounts Payable -- -- -- $16.7M $23.8M
Accrued Expenses -- -- -- $4.1M $3M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $492.7K $574.6K
Other Current Liabilities -- -- -- $15.2M $1.8M
Total Current Liabilities -- -- -- $39M $35.7M
 
Long-Term Debt -- -- -- $8.7M --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $48.4M $36M
 
Common Stock -- -- -- $2K $4.2K
Other Common Equity Adj -- -- -- $23.8K $12.4M
Common Equity -- -- -- $15.8M $79.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $15.8M $79.1M
 
Total Liabilities and Equity -- -- -- $64.3M $115M
Cash and Short Terms -- -- -- $24.1M $68.6M
Total Debt -- -- -- $8.7M --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- $14.3M $47.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $13M $15.3M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -$1K --
Total Current Assets -- -- -- $45.4M $83.8M
 
Property Plant And Equipment -- -- -- $938K $521K
Long-Term Investments -- -- -- -- $600K
Goodwill -- -- -- -- --
Other Intangibles -- -- -- $13M $6.1M
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $59.5M $91M
 
Accounts Payable -- -- -- $17.4M $23.4M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $658K $237K
Other Current Liabilities -- -- -- $72.7M $867K
Total Current Liabilities -- -- -- $103.1M $34.1M
 
Long-Term Debt -- -- -- $14.1M --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $117.8M $34.3M
 
Common Stock -- -- -- $2K $4K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -$58.3M $56.7M
 
Total Liabilities and Equity -- -- -- $59.5M $91M
Cash and Short Terms -- -- -- $14.3M $47.7M
Total Debt -- -- -- $14.1M --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -$31M -$49.7M -$172.5M
Depreciation & Amoritzation -- -- $3.9M $4.8M $7.2M
Stock-Based Compensation -- -- -- -- $67M
Change in Accounts Receivable -- -- -$11.1M $2.7M -$12.2M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$14.4M -$14.6M -$17M
 
Capital Expenditures -- -- $5.4M $5M $2.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$5.5M -$5M -$1.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $13.2M $42.1M $5M
Long-Term Debt Repaid -- -- -$785.5K -$7.3M -$33.5M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$780K -- $91.5M
Cash From Financing -- -- $11.6M $34.8M $63.1M
 
Beginning Cash (CF) -- -- $17.6M $9.2M $24.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$8.3M $15.2M $44.7M
Ending Cash (CF) -- -- $9.2M $24.1M $68.6M
 
Levered Free Cash Flow -- -- -$19.8M -$19.6M -$19.3M
Period Ending 2021-04-01 2022-04-01 2023-04-01 2024-04-01
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-04-01 2022-04-01 2023-04-01 2024-04-01
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2022-04-01 2023-04-01 2024-04-01 2025-04-01 2026-04-01
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 15.53% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 3.89% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is down 1.54% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock